Increase in the prevalence of chronic diseases such as diabetes, hypertension, cancer, and infectious diseases, rise in the awareness of point of care testing, ease of testing procedures and rapid results, and technological advancements such as handheld devices are anticipated to fuel the growth of point of care diagnostics market. Moreover, increase in the R&D for innovation of newer products, rise in healthcare expenditure, and availability of wider products in the market might propel the point of care diagnostics market over the forecast period. However, stringent regulatory policies for the product approvals, lack of reimbursement policies for several home care diagnostics, product recall, and lack of awareness about the point of care testing in the underdeveloped regions might dampen the point of care diagnostics market.A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-point-of-care-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Based on the product type, point of care diagnostics market segmented into the following:
• Infectious Disease Testing Kits
• Cancer/Tumour Markers Testing
• Cardio-Metabolic Monitoring Kits
• Fertility and Pregnancy Testing Kits
• Haematological Testing Kits
• Faecal Occult Testing Kits
• Glucose Monitoring Kits
• Cholesterol Test Strips
• Urinalysis Testing Kits
• Others
Based on the prescription mode, point of care diagnostics market segmented into the following:
• Over-the-counter (OTC) Testing Kits
• Prescription-based Testing Kits
Based on the end user, point of care diagnostics market segmented into the following:
• Hospitals
• Diagnostic centres
• Homecare
• Others
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-point-of-care-diagnostics-market/#ulp-c654SbFYO64MsOhu[/URL]
Point of care diagnostics market is growing at a significant CAGR owing to increase in technological advancements in the innovation of novel devices. Increase in the prevalence of chronic diseases such as diabetes, hypertension, cancer, and other infectious diseases (according to World Health Organisation, global health observatory (GHO) data, in 2013, approximately 34-38 million people suffered from HIV infection) are boosting the point of care diagnostics market. Acquisitions and mergers, collaborations, product approvals, and product launchings are the strategies followed by the companies for increasing their revenue share in global point of care diagnostics market. For instance, in July 2016, Sinocare has acquired PTS diagnostics for diversification of product portfolio. Similarly, in November 2016, Siemens Healthineers entered at the point of care diagnostics market by acquiring Conworx Technology.
Some of the players in point of care diagnostics market are Siemens AG (Germany), Abbott Laboratories, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Becton, Dickinson and Company (U.S.), Mologic Ltd (U.K.), Johnson & Johnson Services Inc. (U.S.), Sinocare, Inc. (China), Roche Diagnostics (U.S.), Nova Biomedical (U.S.), and Instrumentation Laboratory (U.S.) to name a few.
Get Full Summery@
[URL]https://www.precisionbusinessinsights.com/market-reports/global-point-of-care-diagnostics-market/[/URL]
Email: sales@precisionbusinessinsights.com
Toll Free(US): +1-866-598-1553